BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29650929)

  • 1. [A Case of HER2 Positive Occult Breast Cancer Presenting as Swollen Axillary Lymph Nodes].
    Ishiba T; Oda G; Nakagawa T; Akashi T; Yamashita Y; Aburatani T; Ogo T; Nakashima Y; Baba H; Hoshino N; Nishioka Y; Kawano T
    Gan To Kagaku Ryoho; 2018 Mar; 45(3):533-535. PubMed ID: 29650929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of effective trastuzumab plus gemcitabine therapy for human epidermal growth factor receptor 2-positive breast cancer].
    Yabe N; Murai S; Shimizu H; Kitasato K; Yoshikawa T; Oto I; Nakadai J; Jinno H; Kitagawa Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2396-8. PubMed ID: 24394124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of a Bulky Axillary Ectopic Breast Cancer Which Successfully Resected after Chemotherapy(Docetaxel)].
    Takahashi M; Suematsu Y; Yamagishi S; Kanematsu K; Saitou H; Nakayama M; Fukahori M; Wakabayashi K; Ito Y
    Gan To Kagaku Ryoho; 2018 Feb; 45(2):306-308. PubMed ID: 29483429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative genic switch of HER-2 in the primary tumor instead of the synchronous metastatic nodal lesions after neoadjuvant chemotherapy in a patient with primary HER2-positive breast cancer.
    Chen HR; Wu YT; Yu QB; Yang YY; Wei YX; Li HY; Wu KN; Kong LQ
    World J Surg Oncol; 2017 Oct; 15(1):189. PubMed ID: 29052527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Case of Occult Breast Cancer].
    Abe S; Abe N; Noda M; Okano M; Tachibana K; Yoshida S; Kiko Y; Hashimoto Y; Hatakeyama Y; Rokkaku Y; Ohtake T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1095-1097. PubMed ID: 29394545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metachronous secondary primary occult breast cancer initially presenting with metastases to the contralateral axillary lymph nodes: report of a case.
    Kinoshita S; Hirano A; Kobayashi S; Komine K; Kyoda S; Takeyama H; Uchida K; Morikawa T; Nagase J; Sakamoto G
    Breast Cancer; 2010; 17(1):71-4. PubMed ID: 19259764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonimage-guided fine needle aspiration biopsy of palpable axillary lymph nodes in breast cancer patients.
    Marti JL; Ayo D; Levine P; Hernandez O; Rescigno J; Axelrod DM
    Breast J; 2012; 18(1):3-7. PubMed ID: 22098412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary nodal metastasis of occult breast primary cancer.
    Tamiolakis D; Antoniou C
    Chirurgia (Bucur); 2008; 103(4):467-71. PubMed ID: 18780622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Axillary metastases of unknown primary carcinoma].
    Ellend A; Obwegeser R; Auerbach L; Czerwenka K; Kubista E
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):209-13. PubMed ID: 8682287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy.
    Li JW; Mo M; Yu KD; Chen CM; Hu Z; Hou YF; Di GH; Wu J; Shen ZZ; Shao ZM; Liu GY
    PLoS One; 2014; 9(12):e114646. PubMed ID: 25504233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unknown primary carcinoma, diagnosed as inflammatory breast cancer,and successfully treated with trastuzumab and vinorelbine.
    Asakura H; Takashima H; Mitani M; Haba R; Seo R; Yokoe K; Toyama Y; Ohkawa M
    Int J Clin Oncol; 2005 Aug; 10(4):285-8. PubMed ID: 16136377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
    Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult breast carcinoma presenting as an axillary mass.
    Scoggins CR; Vitola JV; Sandler MP; Atkinson JB; Frexes-Steed M
    Am Surg; 1999 Jan; 65(1):1-5. PubMed ID: 9915521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
    Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
    Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical Experience of a Primary Accessory Breast Cancer Patient].
    Ikarashi M; Nagahashi M; Endo M; Otani A; Tsuchida J; Moro K; Niwano T; Yamaura K; Toshikawa C; Hasegawa M; Nakajima M; Sakata J; Kobayashi T; Kameyama H; Wakai T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1104-1106. PubMed ID: 29394548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases.
    Wang X; Zhao Y; Cao X
    Breast J; 2010; 16(1):32-7. PubMed ID: 20465598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
    Porter K; Rosenzweig MQ
    J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.